Three Months Ended December 31,

Six Months Ended December 31,

2024

2023

2024

2023

Net Sales:

North America

$

229,289

$

267,671

$

460,429

$

527,725

International

182,196

186,429

345,652

351,404

$

411,485

$

454,100

$

806,081

$

879,129

Adjusted EBITDA:

North America

$

25,307

$

31,218

$

37,766

$

49,945

International

22,526

25,969

42,896

43,407

Total Reportable Segments Adjusted EBITDA

47,833

57,187

80,662

93,352

Corporate and Other

(9,940

)

(10,061

)

(20,394

)

(22,136

)

37,893

47,126

60,268

71,216

Depreciation and amortization

(11,020

)

(11,197

)

(22,447

)

(23,502

)

Equity in net loss of equity-method investees

(588

)

(907

)

(743

)

(1,405

)

Interest expense, net

(11,993

)

(15,333

)

(24,988

)

(27,956

)

(Provision) benefit for income taxes

(2,728

)

4,249

(6,251

)

9,628

Stock-based compensation, net

(3,573

)

(3,376

)

(6,449

)

(7,118

)

Unrealized currency gains

1,624

194

430

159

Certain litigation expenses, net(a)

(1,020

)

(2,091

)

(1,847

)

(3,615

)

Restructuring activities

Productivity and transformation costs

(4,190

)

(6,869

)

(9,208

)

(13,272

)

Plant closure related costs, net

(858

)

(2,302

)

(1,234

)

(4,143

)

Warehouse/manufacturing consolidation and other costs, net

—

(811

)

—

(811

)

Acquisitions, divestitures and other

Gain (loss) on sale of assets

1,626

—

(2,308

)

(62

)

Transaction and integration costs, net

105

(109

)

423

(227

)

Impairment charges

Goodwill impairment

(91,267

)

—

(91,267

)

—

Intangibles and long-lived asset impairment

(17,986

)

(20,666

)

(18,017

)

(21,360

)

Other

—

(1,443

)

—

(1,443

)

Net loss

$

(103,975

)

$

(13,535

)

$

(123,638

)

$

(23,911

)